Shri Ahimsa Naturals
Key Fundamentals
SMEFood ProductsFMCGPrice-based figures as of · TTM
- ROCE
- 22.80%
- Debt to Equity
- 0.05
- EPS (TTM)
- —
- Book Value
- ₹81.62
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 4.90
- ROE
- 17.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹41.90 Cr
- 52W High
- ₹502.90
- 52W Low
- ₹210.00
- Day Range
- ₹398.00 – ₹405.00
- Volume
- 7,800
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 84/100
Category scores
- Quality
- 81
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 27
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 91
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 87
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 82
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 43
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.3%
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -0.57%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 6 | 4 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 40.45
- Neutral
- MACD (12,26,9)
- −9.93
- Bullish
- SMA (50)
- 439.67
- Bearish
- SMA (200)
- 338.85
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +34.45% |
|---|---|
| 3Y | +5.75% |
| 1Y | +28.13% |
Net profit
| 5Y | +71.88% |
|---|---|
| 3Y | −5.90% |
| 1Y | +36.36% |
Operating cash flow
| 5Y | +31.95% |
|---|---|
| 3Y | −15.66% |
| 1Y | −29.41% |
Operating margin· change in pp
| 5Y | +14.98 pp |
|---|---|
| 3Y | −18.81 pp |
| 1Y | −3.02 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹22.00 Cr |
|---|---|
| Mar 2021 | ₹28.00 Cr |
| Mar 2022 | ₹58.00 Cr |
| Mar 2023 | ₹104 Cr |
| Mar 2024 | ₹78.00 Cr |
| Mar 2025 | ₹96.00 Cr |
| Mar 2026 | ₹123 Cr |
Net profit by year
| Mar 2020 | ₹1.00 Cr |
|---|---|
| Mar 2021 | ₹2.00 Cr |
| Mar 2022 | ₹11.00 Cr |
| Mar 2023 | ₹36.00 Cr |
| Mar 2024 | ₹19.00 Cr |
| Mar 2025 | ₹22.00 Cr |
| Mar 2026 | ₹30.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 41 | 55 | 61 | 63 |
| Expenses | 27 | 38 | 43 | 45 |
| Operating Profit | 14 | 17 | 18 | 18 |
| OPM % | 34% | 30% | 30% | 28% |
| Other Income | 1 | 1 | 3 | 4 |
| Interest | 0 | 1 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 |
| PBT | 13 | 17 | 20 | 20 |
| Tax % | 26% | 26% | 26% | 26% |
| Net Profit | 10 | 12 | 15 | 15 |
| EPS (₹) | 5.08 | 5.25 | 6.36 | 6.5 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 22 | 28 | 58 | 104 | 78 | 96 | 123 |
| Expenses | 18 | 24 | 41 | 54 | 51 | 65 | 87 |
| Operating Profit | 4 | 4 | 17 | 50 | 27 | 31 | 36 |
| OPM % | 17% | 15% | 30% | 48% | 34% | 32% | 29% |
| Other Income | 1 | 0 | 1 | 2 | 1 | 2 | 7 |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| PBT | 2 | 2 | 16 | 51 | 25 | 30 | 40 |
| Tax % | 27% | 32% | 30% | 29% | 26% | 26% | 26% |
| Net Profit | 1 | 2 | 11 | 36 | 19 | 22 | 30 |
| EPS (₹) | 0.98 | 0.96 | 6.16 | 19.51 | 10.21 | 9.42 | 12.84 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 5 | 18 | 23 | 23 |
| Reserves | 6 | 9 | 22 | 58 | 66 | 131 | 171 |
| Borrowings | 14 | 13 | 6 | 3 | 14 | 0 | 9 |
| Other Liabilities | 4 | 4 | 7 | 8 | 5 | 38 | 5 |
| Total Liabilities | 27 | 31 | 41 | 74 | 103 | 193 | 208 |
| Fixed Assets | 15 | 17 | 21 | 28 | 32 | 39 | 38 |
| CWIP | 0 | 1 | 3 | 3 | 6 | 2 | 0 |
| Investments | 0 | 0 | 0 | 1 | 10 | 10 | 35 |
| Other Assets | 12 | 12 | 17 | 42 | 55 | 143 | 135 |
| Total Assets | 27 | 31 | 41 | 74 | 103 | 193 | 208 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 6 | 3 | 14 | 20 | 6 | 17 | 12 |
| Investing | −1 | −4 | −6 | −10 | −19 | −6 | −66 |
| Financing | −5 | 1 | −6 | −4 | 10 | 64 | −12 |
| Net Cash Flow | 0 | 0 | 3 | 7 | −4 | 74 | −66 |
| Free Cash Flow | 5 | −1 | 9 | 10 | −2 | 10 | 13 |
| CFO/EBITDA | 162 | 84 | 91 | 68 | 46 | 73 | 67 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 62 | 25 | 39 | 53 | 96 | 86 |
| Inventory Days | 201 | 61 | 77 | 122 | 340 | 214 | 193 |
| Days Payable | 45 | 33 | 15 | 8 | 18 | 3 | 2 |
| Cash Conversion Cycle | 209 | 90 | 87 | 154 | 375 | 307 | 277 |
| Working Capital Days | −30 | −3 | 26 | 74 | 133 | 92 | 186 |
| ROCE % | — | 14% | 58% | 102% | 32% | 24% | 23% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shri Ahimsa Naturals insights
56 extracted metrics across FY20–FY26.
Documents
- 13 Aug 2026
- 16 May 2025
- 23 Apr 2025
- 16 Feb 2024
- 17 Oct 2026
- 17 Oct 2026
- 28 Sep 2026
- 15 Sep 2026
Frequently Asked Questions about Shri Ahimsa Naturals
What does Shri Ahimsa Naturals Ltd do?
Where is Shri Ahimsa Naturals Ltd (SHRIAHIMSA) listed?
Which sector does Shri Ahimsa Naturals Ltd belong to?
What is the 52-week high and low of Shri Ahimsa Naturals Ltd?
What is the Return on Equity (ROE) of Shri Ahimsa Naturals Ltd?
Company Information
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHRIAHIMSA.md for Shri Ahimsa Naturals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.